Advertisement

Axillary Procedures for Breast Cancer

  • Sara E. HoldenEmail author
  • Heather B. Neuman
Chapter

Abstract

The status of the axillary lymph nodes in breast cancer patients remains an important predictor of overall survival. The complete axillary node dissection has been largely replaced by the sentinel node mapping surgery in the past 15 years. The indications and techniques for sentinel node surgery have evolved over the past 10 years with resultant decreases in operative morbidity.

Keywords

Sentinel node Axillary dissection Axillary lymph nodes Sentinel node mapping Operative morbidity 

References

  1. 1.
    Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52(9):1551–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98(9):599–609.CrossRefPubMedGoogle Scholar
  4. 4.
    Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13(4):491–500.CrossRefPubMedGoogle Scholar
  5. 5.
    Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657–63.CrossRefPubMedGoogle Scholar
  6. 6.
    Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111–8.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–53.CrossRefPubMedGoogle Scholar
  8. 8.
    McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–9.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Del Bianco P, Zavagno G, Burelli P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol. 2008;34(5):508–13.CrossRefPubMedGoogle Scholar
  10. 10.
    McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26(32):5220–6.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Posther KE, McCall LM, Blumencranz PW, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242(4):593–9; discussion 599–602.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4–16.CrossRefPubMedGoogle Scholar
  14. 14.
    Rodier JF, Velten M, Wilt M, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol. 2007;25(24):3664–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of General SurgeryUniversity of Wisconsin Hospital and ClinicsMadisonUSA
  2. 2.Department of SurgeryUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations